Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study

Experimental and Therapeutic Medicine

Volumn 8, Issue 4, 2014, Pages 1205-1208

  Machado Vieira, Rodrigo ^a   Zanetti, Marcus V ^a   de Sousa, Rafael T ^a   Soeiro De Souza, Marcio G ^a   Moreno, Ricardo A ^a   Busatto, Geraldo F ^a   Gattaz, Wagner F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bipolar disorder; Depression; Lithium; Treatment; Trial

Indexed keywords

BENZODIAZEPINE; HYPNOTIC AGENT; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BIPOLAR DEPRESSION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; FEMALE; HAMILTON SCALE; HEADACHE; HUMAN; MALE; NAUSEA; POLYDIPSIA; POLYURIA; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SCORING SYSTEM; SEDATION; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS;

EID: 84906505497     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1864     Document Type: Article

References (16)

1. Judd LL, Akiskal HS, Schettler PJ, et al: A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 60: 261-269, 2003.
2. Merikangas KR, Akiskal HS, Angst J, et al: Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 64: 543-552, 2007.
3. Machado-Vieira R, Manji HK and Zarate CA Jr: The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord 11 (Suppl 2): 92-109, 2009.
4. Forlenza OV, de Paula VJ, Machado-Vieira R, et al: Does lithium prevent Alzheimer's disease? Drugs Aging 29: 335-342, 2012.
5. Haeberle A, Greil W, Russmann S and Grohmann R: Mono-and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP. BMC Psychiatry 12: 153, 2012.
6. Yatham LN, Kennedy SH, Parikh SV, et al: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 15: 1-44, 2013.
7. Gelenberg AJ, Kane JM, Keller MB, et al: Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 321: 1489-1493, 1989.
8. Severus WE, Kleindienst N, Seemüller F, et al: What is the optimal serum lithium level in the long-term treatment of bipolar disorder-a review? Bipolar Disord 10: 231-237, 2008.
9. Nierenberg AA, Friedman ES, Bowden CL, et al: Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. Am J Psychiatry 170: 102-110, 2013.
10. Perlis RH, Sachs GS, Lafer B, et al: Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. Am J Psychiatry 159: 1155-1159, 2002.
11. Coppen A, Abou-Saleh M, Milln P, et al: Decreasing lithium dosage reduces morbidity and side-effects during prophylaxis. J Affect Disord 5: 353-362, 1983.
12. Amsterdam JD and Shults J: Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study. J Clin Psychopharmacol 28: 171-181, 2008.
13. Suppes T, Marangell LB, Bernstein IH, et al: A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. J Affect Disord 111: 334-343, 2008.
14. Young AH, McElroy SL, Bauer M, et al: A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry 71: 150-162, 2010.
15. First MB, Spitzer RL, Gibbon M and Williams J: Structured Clinical Interview for DSM-IV Axis I Disorders. Patient Edition (SCID-I/P). Biometrics Research, New York State Psychiatry Institute, New York, NY, 1995.
16. Nolen WA and Weisler RH: The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144). Bipolar Disord 15: 100-109, 2013.